Literature DB >> 12802928

Pulmonary alveolar proteinosis in a patient with acute lymphoid leukemia regression after G-CSF therapy.

Gülsüm Emel Pamuk1, Burhan Turgut, Ozden Vural, Muzaffer Demir, Osman Hatipoğlu, Ercüment Unlü, Semsi Altaner, Murat Gerenli, Bilge Cakir.   

Abstract

Pulmonary alveolar proteinosis (PAP) is the intra-alveolar accumulation of periodic-acid schiff (PAS) positive material. PAP is one of the underrecognized causes of pulmonary infiltrates in patients with hematologic malignancies. Here, we present a patient with acute lymphoid leukemia (ALL) in first remission that developed fever and diffuse pulmonary infiltrates during the neutropenic stage of consolidation chemotherapy. The histopathologic examination of bronchoalveolar lavage (BAL) fluid and transbronchial biopsy specimen demonstrated the presence of PAS-positive eosinophilic material. Empirical antibiotherapy and granulocyte-colony stimulating factor (G-CSF) were given. After the correction of neutropenia with G-CSF, the patient's fever disappeared, acute phase reactants decreased, pulmonary infiltrates resolved. We present this case because it was the first patient in whom the correction of neutropenia with G-CSF was followed by resolution of PAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802928     DOI: 10.1080/1042819021000055093

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

Review 1.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

2.  Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.

Authors:  Jonathan H Chung; Sudhakar J Pipavath; David H Myerson; David Godwin
Journal:  J Thorac Imaging       Date:  2009-05       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.